NeuroOne Medical Technologies Corporation
NMTC
$0.567
-$0.0126-2.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1,102.42% | -67.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,102.42% | -67.03% | |||
| Cost of Revenue | 102.40% | -28.40% | |||
| Gross Profit | 177.60% | -6.55% | |||
| SG&A Expenses | 10.81% | -1.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -49.40% | -14.66% | |||
| Operating Income | 160.75% | -0.82% | |||
| Income Before Tax | 153.28% | -21.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 153.28% | -21.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 153.28% | -21.07% | |||
| EBIT | 160.75% | -0.82% | |||
| EBITDA | 164.53% | -0.80% | |||
| EPS Basic | 151.51% | -11.07% | |||
| Normalized Basic EPS | 151.57% | -11.08% | |||
| EPS Diluted | 151.51% | -11.07% | |||
| Normalized Diluted EPS | 151.42% | -11.08% | |||
| Average Basic Shares Outstanding | 3.45% | 8.98% | |||
| Average Diluted Shares Outstanding | 3.59% | 8.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||